Scinovex
article Open AccessTop 1% cited

Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors

Bioorganic & Medicinal Chemistry Letters · 2004 · Vol. 15(3) · pp. 761–764
Craig W. LindsleyZhijian ZhaoWilliam LeisterR. RobinsonStanley F. BarnettDeborah Defeo-JonesRaymond E. JonesGeorge D. HartmanJoel R. HuffHans E. HuberMark E. Duggan
Quinazolinone synthesis and applicationsPI3K/AKT/mTOR signaling in cancerSynthesis and Biological EvaluationAKT1AKT2Protein kinase BChemistryAllosteric regulationPhosphorylationIn vivoKinaseEnzyme inhibitorBiochemistry

MeSH terms

Allosteric RegulationEnzyme InhibitorsHumansIsoenzymesPhosphorylationProto-Oncogene ProteinsQuinoxalinesStructure-Activity RelationshipApoptosisProtein Serine-Threonine KinasesInhibitory Concentration 50Proto-Oncogene Proteins c-akt
Citations
499
FWCI
14.59
field-weighted impact
References
19
Percentile
100%
vs. same field & year
Citations per year
Cited by
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
Nature Reviews Drug Discovery · 2005 · 2,158 citations
Targeting cancer with small molecule kinase inhibitors
Nature reviews. Cancer · 2008 · 2,539 citations
Related articles
Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors
Bioorganic & Medicinal Chemistry Letters · 2004 · 499 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors · Scinovex